Ellen Brennan, NP
Adult Health · Wilmington, DENPI 1821729039
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 42.8% of the total.
Across 32 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$226
- Scilex Pharmaceuticals Inc.$148
- Biohaven Pharmaceutical Holding Company Ltd.$50
- IBSA Pharma Inc.$23
- AbbVie$21
- Redhill Biopharma Inc.$21
- plus $39 from 2 others
What the payments were for
- Food & beverage$528100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $226 |
| Scilex Pharmaceuticals Inc. | 8 | $148 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $50 |
| IBSA Pharma Inc. | 1 | $23 |
| AbbVie | 1 | $21 |
| Redhill Biopharma Inc. | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $20 |
| Protega Pharmaceutials Inc | 1 | $19 |
How this compares
$528 in reported general payments places this provider in the 60th percentile of 65 adult health providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 12 | $7,755 |
| EliquisApixaban | 19 | $5,722 |
| Memantine Hcl | 12 | $1,093 |
| Atorvastatin Calcium | 24 | $385 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 16 | $369 |
| Levothyroxine Sodium | 23 | $195 |
| Cyclobenzaprine Hcl | 14 | $181 |
| Lorazepam | 14 | $163 |
| Amlodipine Besylate | 19 | $155 |
| Potassium Chloride | 13 | $151 |
| Warfarin Sodium | 15 | $117 |
| Metoprolol Tartrate | 17 | $97 |
Paid to pharmacies, not to this prescriber.
Other adult health in Wilmington
- Emily KellerWilmington$26K
- Mary HighWilmington$8K
- Adrienne WoodsWilmington$2K
- Dannette MitchellWilmington$2K
- Alexandra HarisWilmington$1K
- Mary NairnWilmington$1K
- Aruna MuthukumarWilmington$657
- Margaret Corrigan MasseyWilmington$513
- Nicole ScottWilmington$267
- Stephanie MoonWilmington$264
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.